Enoxaparin

انوکساپارین

⚠ Unverified

🩸 Blood And Blood Forming OrgansLow-molecular-weight heparin

Market / country: 🇺🇸 USA

Lovenox (US) · Clexane (GB)

🧮 Dose calculator

Venous thromboembolism prophylaxis (medical or surgical) · Regimen source: FDA Enoxaparin · 2.2

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

  • ⛔ Active major bleeding; HIT within the past 100 days; hypersensitivity to enoxaparin, heparin or pork products. FDA Enoxaparin · 4

Warnings

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Enoxaparin · 8.1

    “Risk Summary Placental transfer of enoxaparin was observed in the animal studies.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Enoxaparin · 8.2

    “In lactating rats, the passage of enoxaparin or its metabolites in the milk is very limited.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Enoxaparin · 8.4

    “Safety and effectiveness of Enoxaparin Sodium Injection in pediatric patients have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Enoxaparin · 8.5

    “Monitoring of geriatric patients with low body weight (<45 kg) and those predisposed to decreased renal function should be considered [ see Warnings and Precautions ( 2.6 ) and Clinical Pharmacology ( 12.3 ) ].”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav